Suscribirse para recibir un email cada vez que se introduzca un ítem en esta colección.

Vista previa	Fecha de publicación	Fecha de Creación	Título
	sep-2023	-	Circulating ST2, from biomarker to pathogenic mediator
	may-2023	-	Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis
	2023	-	Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
	2023	-	The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
	may-2022	-	Myocardial Remoding: Mechanisms and Translational Implications
	may-2022	-	Critical warm ischemia time point for cardiac donation after circulatory death
	feb-2021	-	The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI
	2021	-	Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency
	ago-2020	-	Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
	2020	-	Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project.
	oct-2019	-	Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
	jul-2019	-	Reply: Interleukin-1β and sST2
	abr-2019	-	Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction
	mar-2019	-	The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure
	2019	-	Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries
	2019	-	A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infection
	2019	-	MPI-CDG with transient hypoglycosylation and antithrombin deficiency
	sep-2018	-	Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction
	2018	-	Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers.
	dic-2017	-	Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction